Company
Moleculin Biotech, Inc.
MBRX · CIK 0001659617
Acquisition (code M) of 130,000 shares; price not stated (see filing).
Reporting Person Foster Jonathan P. · Officer Title Chief Financial Officer · Transaction Code M
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001437749-26-032864 · filed 2026-10-16 · View filing →
Disposition (code F) of 30,485 shares at $0.3701 per share.
Reporting Person Foster Jonathan P. · Officer Title Chief Financial Officer · Transaction Code F
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001437749-26-032864 · filed 2026-10-16 · View filing →
Acquisition (code M) of 207,500 shares; price not stated (see filing).
Reporting Person KLEMP WALTER V · Officer Title CEO and President · Transaction Code M
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001437749-26-032865 · filed 2026-10-16 · View filing →
Disposition (code F) of 48,659 shares at $0.3701 per share.
Reporting Person KLEMP WALTER V · Officer Title CEO and President · Transaction Code F
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001437749-26-032865 · filed 2026-10-16 · View filing →